Singapore markets close in 5 hours 32 minutes

Santen Pharmaceutical Co., Ltd. (SNPHF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
9.450.00 (0.00%)
At close: 12:19PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 3.42B
Enterprise value 2.88B
Trailing P/E 19.43
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)1.78
Price/book (mrq)1.76
Enterprise value/revenue 0.01
Enterprise value/EBITDA 0.05

Trading information

Stock price history

Beta (5Y monthly) 0.26
52-week change 320.23%
S&P500 52-week change 321.61%
52-week high 310.60
52-week low 37.86
50-day moving average 39.65
200-day moving average 39.32

Share statistics

Avg vol (3-month) 350
Avg vol (10-day) 3N/A
Shares outstanding 5363.26M
Implied shares outstanding 6365.15M
Float 8349.13M
% held by insiders 12.79%
% held by institutions 145.38%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.22
Forward annual dividend yield 42.34%
Trailing annual dividend rate 332.00
Trailing annual dividend yield 3338.70%
5-year average dividend yield 42.07
Payout ratio 442.91%
Dividend date 327 Jun 2018
Ex-dividend date 428 Mar 2024
Last split factor 25:1
Last split date 327 Mar 2015

Financial highlights

Currency in JPY.

Fiscal year

Fiscal year ends 31 Mar 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 9.18%
Operating margin (ttm)14.36%

Management effectiveness

Return on assets (ttm)12.03%
Return on equity (ttm)9.26%

Income statement

Revenue (ttm)302.08B
Revenue per share (ttm)815.26
Quarterly revenue growth (yoy)8.70%
Gross profit (ttm)N/A
EBITDA 99.33B
Net income avi to common (ttm)27.71B
Diluted EPS (ttm)0.49
Quarterly earnings growth (yoy)22.70%

Balance sheet

Total cash (mrq)83.36B
Total cash per share (mrq)229.51
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)2.46
Book value per share (mrq)822.49

Cash flow statement

Operating cash flow (ttm)68.11B
Levered free cash flow (ttm)76.02B